228.74MMarket Cap
LossP/E TTM
PRQR Balance Sheet
You can check out the annual or quarterly balance sheets of ProQR Therapeutics NV here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing PRQR stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does ProQR Therapeutics NV Have?
In its most recent quarterly, ProQR Therapeutics NV had 95.17M in cash and cash equivalents.
How Much Are ProQR Therapeutics NV's Total Liabilities?
ProQR Therapeutics NV reported 72.95M in total liabilities as of the latest reported quarter, including 37.34M in current liabilities and 35.61M in non-current liabilities.
What Are ProQR Therapeutics NV's Total Assets?
As of the latest reported quarter, ProQR Therapeutics NV's total assets were 129.78M, consisting of 115.24M in current assets and 14.54M in non-current assets.
How Much Shareholders' Equity Does ProQR Therapeutics NV Have?
ProQR Therapeutics NV reported 56.83M in total shareholders' equity as of the latest reported quarter.